English press releases

ABB Shows the Factory of the Future to German Chancellor and PM of Sweden

Federal Chancellor Angela Merkel and the Swedish Prime Minister Stefan Löfven were given a glimpse into the factory of the future by ABB CEO Ulrich...

ABB and Ericsson Join Forces to Accelerate Wireless Automation for Flexible Factories

HANNOVER, Germany–(BUSINESS WIRE)– ABB and Ericsson today strengthened their long-standing relationship with the signing of a Memorandum of Understanding (MoU) at Hannover Messe 2019. The...

Notice of ABB’s Annual General Meeting on May 2, 2019

ZURICH–(BUSINESS WIRE)– ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, May 2, 2019. The invitation can...

Elliott Statement on Telecom Italia

MILAN & LONDON–(BUSINESS WIRE)– Elliott Advisors (UK) Limited (“Elliott”) welcomes Vivendi’s decision to withdraw its request to shareholders to revoke five of Telecom Italia’s (“TIM”)...

Arch Announces European Brexit Changes

DUBLIN–(BUSINESS WIRE)– Arch Insurance International and Arch MI today announced changes to their European operations as part of the Arch Brexit plan and other recent...

Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-Based Triplet Combination Regimens for Patients with Multiple Myeloma

The CHMP adopted two positive opinions recommending European Commission approval of: REVLIMID in combination with bortezomib and dexamethasone (RVd) in adult patients with previously untreated...

Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics

New molecular platform to access intracellular targets across a broad range of tumor cell types Opens up new range of therapeutic opportunities for difficult-to-treat cancers...

bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia (TDT) Who Do Not Have β0/β0 Genotype

First gene therapy recommended for approval in the EU for TDT Treatment with ZYNTEGLO has been shown to help eliminate the need for chronic blood...

Success of Thales Offer for Gemalto Shares

85.58% of Gemalto shares have been tendered to the Offer All Offer Conditions are now satisfied or waived, making the Offer unconditional Settlement of tendered...

Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients

— Filgotinib 100 mg and 200 mg Plus Methotrexate (MTX) Demonstrated Significantly Higher ACR20/50/70 Responses Than Methotrexate Alone — — Filgotinib Safety Profile Consistent With...

Gilead and Galapagos Announce Filgotinib Meets Primary and Key Secondary Endpoints in the Phase 3 FINCH 1 Rheumatoid Arthritis Study

— Filgotinib 100 mg and 200 mg Doses Demonstrated Significantly Higher ACR20/50/70 Responses than Placebo in Patients with Prior Inadequate Methotrexate Response — — Significant...

Gilead and Galapagos Report Updated Safety Information for Filgotinib in Rheumatoid Arthritis (RA)

— Pooled Interim Phase 3 FINCH Program Data up to 24 Weeks and Phase 2b DARWIN 3 Long-Term Data Add to Evidence Supporting Filgotinib Safety...

Resolutions of the Annual Shareholders’ Meeting of Sartorius AG

GÖTTINGEN, Germany–(BUSINESS WIRE)– At today’s Annual Shareholders’ Meeting in Göttingen, Germany, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the...

Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia

— Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates — — Harm Reduction Coalition Selected as Lead...

Elliott Submits Agenda Item for EDP’s Upcoming AGM

PROVIDES SHAREHOLDERS A DETERMINATIVE VOTE ON CTG’S TAKEOVER BID CLARIFIES EDP’S CURRENT SITUATION AND CHARTS CLEAR PATHWAY FORWARD LISBON, Portugal & LONDON–(BUSINESS WIRE)– Funds advised...